Current understanding of COVID-19 clinical course and investigational treatments
RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
Possible therapeutic agents for COVID-19: a comprehensive review
KM Elhusseiny, FAE Abd-Elhay… - Expert Review of Anti …, 2020 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
Treatment options for COVID-19: a review
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
Coronavirus disease 2019 treatment: a review of early and emerging options
EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
An updated review on COVID-19
Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …
[HTML][HTML] Perspective: repurposed drugs for COVID-19
K Na-Bangchang, S Porasuphatana… - Archives of Medical …, 2022 - ncbi.nlm.nih.gov
Methods Research articles and guidelines related to therapy of COVID-19 were searched
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
[HTML][HTML] Emerging pharmaceutical treatments of novel COVID-19: a review
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …
the current global pandemic. Research has been focusing on studying the structure of SARS …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
Potential limitations in systematic review studies assessing the effect of the main intervention for treatment/therapy of COVID-19 patients: An overview
M Mohseni, H Ameri, M Arab-Zozani - Frontiers in Medicine, 2022 - frontiersin.org
Background Although several studies have assessed the safety, efficacy, and effectiveness
of interventions in treating the COVID-19, many of them have limitations that can have an …
of interventions in treating the COVID-19, many of them have limitations that can have an …
[PDF][PDF] Pharmacological treatments of covid-19-a review
JM Cherumanalil, J Thayyil - Asian J Pharm Clin Res, 2020 - kmctmedicalcollege.org
Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …